Huron Consulting Group Inc. (NASDAQ:HURN) Director James H. Roth Sells 2,000 Shares

Huron Consulting Group Inc. (NASDAQ:HURN) Director James H. Roth sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, January 8th. The stock was sold at an average price of $123.69, for a total value of $247,380.00. Following the transaction, the director now directly owns 50,534 shares in the company, valued at $6,250,550.46. This trade represents a 3.81 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Huron Consulting Group Stock Down 0.4 %

HURN stock opened at $124.10 on Tuesday. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 0.82. The firm has a market capitalization of $2.20 billion, a PE ratio of 26.98 and a beta of 0.60. Huron Consulting Group Inc. has a 1-year low of $84.26 and a 1-year high of $131.06. The business’s 50 day simple moving average is $123.20 and its 200 day simple moving average is $112.20.

Huron Consulting Group (NASDAQ:HURN) last posted its earnings results on Tuesday, October 29th. The business services provider reported $1.68 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.11. Huron Consulting Group had a return on equity of 21.51% and a net margin of 5.80%. The business had revenue of $370.00 million for the quarter, compared to analyst estimates of $377.63 million. During the same period in the previous year, the firm earned $1.39 EPS. The firm’s revenue was up 3.3% compared to the same quarter last year. As a group, research analysts anticipate that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on HURN shares. Benchmark reaffirmed a “buy” rating and set a $140.00 price target on shares of Huron Consulting Group in a research report on Wednesday, October 30th. StockNews.com raised Huron Consulting Group from a “hold” rating to a “buy” rating in a research report on Thursday, October 31st. Finally, Barrington Research boosted their price target on Huron Consulting Group from $137.00 to $142.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $133.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HURN. Ashton Thomas Private Wealth LLC acquired a new position in Huron Consulting Group in the 2nd quarter valued at $28,000. Assetmark Inc. grew its holdings in Huron Consulting Group by 7.0% in the 3rd quarter. Assetmark Inc. now owns 1,373 shares of the business services provider’s stock valued at $149,000 after buying an additional 90 shares in the last quarter. MML Investors Services LLC acquired a new position in Huron Consulting Group in the 3rd quarter valued at $220,000. Peapack Gladstone Financial Corp acquired a new position in Huron Consulting Group in the 3rd quarter valued at $220,000. Finally, Orion Portfolio Solutions LLC bought a new stake in shares of Huron Consulting Group during the 3rd quarter valued at $264,000. 93.90% of the stock is owned by institutional investors and hedge funds.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.